Kevin Norrett insider trades

Open-market stock purchases and sales by Kevin Norrett, Chief Business Officer at Soleno Therapeutics Inc, from SEC Form 4 filings since Aug 10, 2020.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +49%.

Recent trades

DateStockTradeValue
May 18, 2026SLNO Soleno Therapeutics IncSold (not open market)—
May 18, 2026SLNO Soleno Therapeutics IncSold (not open market)$3M
May 18, 2026SLNO Soleno Therapeutics IncSold (not open market)$175K
Jan 21, 2026SLNO Soleno Therapeutics IncBought (not open market)—
Jan 21, 2026SLNO Soleno Therapeutics IncBought (not open market)—
Nov 17, 2025SLNO Soleno Therapeutics IncBought (not open market)—
Nov 17, 2025SLNO Soleno Therapeutics IncBought (not open market)—

Companies traded

  • SLNO Soleno Therapeutics Inc: other filings, last May 18, 2026
  • CDXS Codexis, Inc: 1 buy, 2 sales, last Feb 5, 2025
  • SRRA Sierra Oncology, Inc: other filings, last Jul 1, 2022

Get free alerts when Kevin Norrett files a new trade →